Newsroom

SAN JOSE, Calif.--(BUSINESS WIRE)--Cadence Reports Fourth Quarter and Fiscal Year 2025 Financial Results...

阿联酋阿布扎比--(BUSINESS WIRE)--(美国商业资讯)-- 阿联酋领先房地产开发商Ohana Development正式推出“Manchester City Yas Residences by Ohana”项目，这是位于阿布扎比亚斯运河的滨水封闭式社区，项目总投资41亿美元，也是曼城足球俱乐部在全球的首个品牌住宅项目。 该项目在阿布扎比阿提哈德公园正式发布，Ohana Development首席执行官Husein Salem、首席运营官Mustafa El Sammak以及City Football Group首席执行官Ferran Soriano出席了发布会。 活动期间，阿布扎比房地产中心宣布，通过其Madhmoun平台实现期房购买意向登记和预订流程数字化，在阿布扎比推出全新监管框架。相关登记将由阿布扎比房地产中心(ADREC)直接监管，并实行强制托管账户管理，从而加强投资者保护、透明度和治理水平。 项目总占地面积167万平方米，将提供超过2000套住宅单元，包括6个别墅区（4居室、5居室别墅和双联别墅）、复式公寓、滨水顶层套房和普通公寓。独栋别墅均价为190万美元。...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded age indication for EVO/EVO+ Visian® Implantable Collamer Lenses, extending use to patients 21 to 60 years old. The approval came shortly after publication of three-year FDA clinical trial safety data, reinforcing...

FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the TD Cowen 46th Annual Healthcare Conference on Tuesday, March 3, 2026 at the Boston Marriott Copley Place in Boston, MA. About Personalis, Inc. At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding...

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strategic focus for 2026. “On my first investor call in October, I committed to advancing three strategic objectives in my first 100 days: reset our business strategy, recover our market leadership with independent physician practices and reignite profitable growth,” said...

SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics and infectious disease vaccines, today announced that it will release its financial results for the quarter and year ended December 31, 2025 after the market close on Tuesday, March 3 and will also host a conference call and webcast at 4:30 p.m. Eastern Time on March 3...

LAS VEGAS & RENO, Nev.--(BUSINESS WIRE)--Caesars Entertainment, Inc., (NASDAQ: CZR) (“Caesars,” “CZR,” “CEI” or “the Company”) today reported operating results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter Results: GAAP net revenues of $2.9 billion versus $2.8 billion for the comparable prior-year period. GAAP net loss of $250 million compared to net income of $11 million for the comparable prior-year period, with the decrease primarily driven by gains on asset sa...

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced fourth quarter 2025 and full year 2025 financial results. “Our 2025 performance reflects strong execution and continued momentum in our business. We delivered 15% revenue growth for the year and strengthened profitability while advancing key innovation and c...

WESTCHESTER, Ill.--(BUSINESS WIRE)--RB Global, Inc. (NYSE & TSX: RBA, the “Company”, “RB Global”, “we”, “us”, “their”, or “our”) reported the following results for the three months and year ended December 31, 2025. “I am incredibly proud of what the RB Global team achieved in 2025,” said Jim Kessler, CEO of RB Global. “This year, we advanced our strategic priorities, enhanced our operating model, and delivered meaningful value for our customers, partners and shareholders.” Commenting on the...

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today its fourth quarter and full-year 2025 financial results will be released on Monday, March 2, 2026, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET, during which management will discuss the Company’s financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit the Investor...